---
title: "Chinese healthcare firms expand overseas to support growing expat community"
description: "Chinese healthcare firms are expanding overseas to serve expatriate communities, particularly in the Middle East and Southeast Asia. Distinct Healthcare Holdings plans to open a clinic in Dubai after "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/275545078.md"
published_at: "2026-02-11T03:16:20.000Z"
---

# Chinese healthcare firms expand overseas to support growing expat community

> Chinese healthcare firms are expanding overseas to serve expatriate communities, particularly in the Middle East and Southeast Asia. Distinct Healthcare Holdings plans to open a clinic in Dubai after raising HK$284.53 million from its IPO in Hong Kong. Traditional Chinese medicine companies like Sichuan Neautus are also exporting products to Southeast Asia, capitalizing on the demand from overseas Chinese communities. Gushengtang Holdings aims to open 50 clinics in the region by 2026. This trend reflects a broader movement of mainland companies utilizing Hong Kong's capital markets for international expansion.

Chinese healthcare companies are looking to expand overseas to serve Chinese communities in regions such as the Middle East and Southeast Asia, where many mainland companies are setting up operations across sectors. “A wide range of Chinese companies are expanding overseas,” setting up local operations and bringing Chinese employees with them, said Philip Wang, CEO of Distinct Healthcare Holdings, in an interview on Monday. “Chinese expatriate workers are often not familiar with the local healthcare system,” said Wang. “If there is a Chinese-run clinic, they may come to us. We can help bridge the language gap … or we can help connect them with some local resources to assist them.” He added that the company plans to follow the flow of Chinese customers into international markets. The Shenzhen-based private healthcare service provider plans to open its first clinic in Dubai, the financial hub of the United Arab Emirates, this year, after making inroads earlier into Singapore and Kuala Lumpur, Malaysia. On Friday, Distinct Healthcare raised HK$284.53 million (US$36.4 million) from its initial public offering (IPO) in Hong Kong, according to an exchange filing. Its stock has lost about 12 per cent since the listing, closing at HK$59.90 on Tuesday. Most of its clinics and hospitals are in top tier mainland Chinese cities, such as Shenzhen, Guangzhou, Beijing, Shanghai and Hangzhou. Traditional Chinese medicine (TCM) firms are also capitalising on the trend. Sichuan Neautus Traditional Chinese Medicine has been exporting its products to Southeast Asian countries, such as Vietnam, Thailand and Malaysia. “The surge of Chinese firms expanding overseas and bringing their workforce to these regions has helped lift demand for our products,” said Jiang Feng, general manager of Sichuan Neautus, which filed an application for an IPO in Hong Kong in October. The provider of decoction-ready products plans to use a portion of its proceeds to build overseas sales channels in Vietnam and Malaysia by 2027, according to its IPO application. TCM companies are also tapping overseas Chinese communities and local interest in herbal medicines. “There are many large overseas Chinese communities in Southeast Asia, and the long-standing influence of traditional Chinese medicine in the region has also drawn local customers to TCM products,” said Jiang. Hong Kong-listed TCM group Gushengtang Holdings was set to expand into Southeast Asia, with plans to open up to 50 clinics in the region by the end of 2026, according to Chinese media reports. It operated 83 medical centres on the mainland as of June 2025, according to its interim report. The Chinese healthcare sector’s overseas push is part of a growing trend of mainland companies using Hong Kong’s capital markets since last year to finance their overseas projects. These include Contemporary Amperex Technology’s US$5.2 billion share sale. About 90 per cent of the proceeds have been earmarked for a battery production facility in Hungary. China’s largest fresh-drink chain Mixue Group said it would use the IPO funds to build a new logistics hub in Southeast Asia, while Suzhou-based analogue chipmaker Novosense Microelectronics plans to turn its Hong Kong office into its overseas headquarters.

### Related Stocks

- [02273.HK - GUSHENGTANG](https://longbridge.com/en/quote/02273.HK.md)
- [02677.HK - DISTINCT HEALTH](https://longbridge.com/en/quote/02677.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 固生堂将通过溢价发行的可转换债券筹集 1.1 亿美元，以推动人工智能驱动的中医药发展 | 固生堂控股有限公司（香港股票代码：2273）已宣布通过未上市可转换债券签署一项融资协议，筹集 1.1 亿美元，债券价格为每股 37.77 港元，溢价 22%。这笔资金将用于股票回购、对传统中医（TCM）的人工智能投资以及一般营运资金。此举旨 | [Link](https://longbridge.com/en/news/273714170.md) |
| 港股异动：冠泽医疗跌 10.11%，财务忧虑与行业疲软双重打击股价 | GUANZE MEDICAL 跌 10.11%；国药控股涨 3.15%，成交额达到 50.96 百万港币；健康 160 涨 1.89%，成交额达到 43.96 百万港币；药师帮涨 0.61%，成交额达到 6.26 百万港币；上海医药涨 2. | [Link](https://longbridge.com/en/news/276572917.md) |
| ICU 医疗｜10-K：2025 财年营收 22.31 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276382836.md) |
| 巨大的 “智能体蓝海市场”：软件编程占一半，医疗、金融、法律等 “寥寥无几” | 一项关于 AI 智能体应用的研究显示，软件工程占据市场的 49.7%，而医疗、法律、金融等领域的市场份额均不足 5%。这表明创业者应关注未被开发的蓝海市场。研究还指出，AI 模型的能力远超用户信任，存在巨大的应用潜力。Y Combinato | [Link](https://longbridge.com/en/news/276575566.md) |
| 港股异动：京玖康疗大涨 22.88%，资金流向明显，市场情绪高涨背后隐藏何种风险？ | 京玖康疗大涨 22.88%；健康之路涨 8.52%，成交额达到 34.75 百万港币；环球医疗涨 3.43%，成交额达到 13.17 百万港币；锦欣生殖涨 3.24%，成交额达到 11.09 百万港币；固生堂涨 1.35%，市值达到 69. | [Link](https://longbridge.com/en/news/276570107.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.